Granules Life Sciences secures first U.S. FDA approval
“We plan on launching the product in the U.S. market soon. It is an already approved product at our Gagillapur facility, but we plan on building market share with this approval,” Granules India CMD Krishna Prasad Chigurupati said in a release. | Photo Credit: Photo Courtesy: www.linkedin.com/in/krishna-prasad-chigurupati Generic drugmaker Granules India subsidiary Granules Life Sciences…
Read More “Granules Life Sciences secures first U.S. FDA approval” »